| Unique ID issued by UMIN | UMIN000062665 |
|---|---|
| Receipt number | R000071740 |
| Scientific Title | Evaluation of a Prevention Education Program for Developmental Dysplasia of the Hip: A Pilot Study |
| Date of disclosure of the study information | 2026/08/24 |
| Last modified on | 2026/08/24 13:12:09 |
Research on Infant Hip Health and Parenting
Research on Infant Hip Health and Parenting
Evaluation of a Prevention Education Program for Developmental Dysplasia of the Hip: A Pilot Study
Evaluation of a Prevention Education Program for Developmental Dysplasia of the Hip: A Pilot Study
| Japan |
Developmental dysplasia of the hip
| Pediatrics | Orthopedics | Nursing |
| Adult | Child |
Others
NO
To provide face-to-face developmental dysplasia of hip (DDH) prevention education to pregnant women and to examine the effectiveness, acceptability, and feasibility of the education program by assessing changes in behavior, intention, knowledge, attitude, and self-efficacy during pregnancy and after childbirth.
Efficacy
Frequency of DDH preventive behaviors (Period: 1 to 2 months postpartum)
Behavioral intention, knowledge, attitude, and self-efficacy about DDH prevention
Subject evaluation of program acceptability
Interventional
Parallel
Non-randomized
Open -no one is blinded
No treatment
2
Educational,Counseling,Training
| Behavior,custom |
face-to-face education on DDH prevention (approximately 60 min)
No treatment
| 18 | years-old | <= |
| Not applicable |
Female
1. Pregnant women who are between 22 weeks 0 days and 36 weeks 6 days of gestation on the date of the educational program or the corresponding reference date
2. Women who are pregnant with their first child
3. Women aged 18 years or older
4. Women who are able to read, write, and understand Japanese
If the target sample size cannot be achieved, the criterion requiring participants to be pregnant with their first child may be removed.
1. Women with multiple pregnancies
2. Women with diseases or disabilities that may make participation in the study difficult (e.g. severe mental disorders, visual or hearing impairments)
3. Women with high-risk pregnancies (e.g. placenta previa, hypertensive disorders of pregnancy, fetal growth restriction)
4. Women whose fetus has been identified by a physician as having a congenital condition (e.g. congenital heart disease, cleft lip and palate, Down syndrome)
40
| 1st name | Kyoko |
| Middle name | |
| Last name | Yoshioka-Maeda |
The University of Tokyo
Graduate School of Medicine
1130033
7-3-1 Hongo, Bunkyo-ku, Tokyo
0358413597
faculty_chiiki-group@g.ecc.u-tokyo.ac.jp
| 1st name | Fumiyuki |
| Middle name | |
| Last name | Tanaka |
The University of Tokyo
Graduate School of Medicine
1130033
7-3-1 Hongo, Bunkyo-ku, Tokyo
0358413597
fumiyukitanaka@g.ecc.u-tokyo.ac.jp
The University of Tokyo
MEXT
Japanese Governmental office
Research Ethics Committee of the Faculty of Medicine of the University of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo
03-5841-0818
ethics@m.u-tokyo.ac.jp
NO
| 2026 | Year | 08 | Month | 24 | Day |
Unpublished
Preinitiation
| 2026 | Year | 08 | Month | 24 | Day |
| 2026 | Year | 08 | Month | 24 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 08 | Month | 24 | Day |
| 2026 | Year | 08 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071740